IOL Chemicals and Pharmaceuticals Limited, a leading producer of both pharmaceuticals and specialty chemicals, has chosen Vikas Vij as its new Chief Executive Officer. With over three decades of experience in the pharma sector, including leadership positions at Cipla, Ranbaxy, and Alembic Pharmaceuticals, Vij brings a wealth of expertise and a sharp understanding of the industry to the table.
Joint Managing Director of IOL Chemicals and Pharmaceuticals, Vikas Gupta, commented, “We’re thrilled to welcome Vikas Vij as CEO of IOL Chemicals and Pharmaceuticals. With his exceptional skills and experience, we’re confident that he will lead IOL to new heights, both in India and in other markets. His deep understanding of the pharma value chain, including Active Pharmaceutical Ingredients (API), Finished Dosage Forms (FDF), and Custom Pharmaceutical Services (CRAMS), will be instrumental in driving portfolio enhancement and operational efficiencies for IOL.”
Vij takes over from Dr Sanjay Chaturvedi, who has played an integral role in the success of IOL Chemicals and Pharmaceuticals. With a well-established reputation in the industry and a commitment to sustainability and responsible operations, IOL Chemicals and Pharmaceuticals is well-positioned for continued growth and success with Vij at the helm.
On his appointment, Vij said, “I’m excited to join forces with the talented team at IOL and help drive the company’s next phase of growth. It’s an honor to lead a company that is making such a positive impact on people’s lives and on the Indian Pharmaceutical Industry.”
IOL Chemicals and Pharmaceuticals boasts a world-class facility and a strong presence across major therapeutic categories, with a product portfolio that includes APIs like Ibuprofen and specialty chemicals like Ethyl Acetate. The company is committed to sustainability and operates with a Zero Liquid Discharge Effluent Treatment Plant and a 17 MW captive Co-Generation plant.
